A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Generalized Anxiety Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • SLaM, London, United Kingdom

    Contact: Study coordinator (Principal Investigator)
Study leads
  • Allan Young

    Principal Investigator

    SLaM